Downtrend on the daily chart: below its 50- and 200-day averages · 50-day below the 200-day · SuperTrend down since Sep 11 · below the Ichimoku cloud · RSI 25 (oversold) · MACD below its signal · 1% above its 52-week low
None of the 29 investors followed here reported a position in TLRY in their latest filing.
From each investor's quarterly 13F filing with the SEC: positions at the quarter's end, reported up to 45 days later. All investors
No member of Congress has disclosed a TLRY trade since 2025.
From House and Senate STOCK Act reports. Members disclose trades, not holdings, as value ranges up to 45 days later, so amounts are estimates and “last move” is a hint at who still holds it, not a position. All recent congress trades
| Date | Insider | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 25, 2026 | Merton Carl A.Chief Financial Officer | — | 168.5K | — |
| Aug 25, 2026 | Faltischek Denise MOfficer | — | 178.2K | — |
| Aug 25, 2026 | Simon Irwin DavidChief Executive Officer | — | 1.21M | — |
| Aug 25, 2026 | Gendel Mitchell SGeneral Counsel | — | 160.3K | — |
| Aug 5, 2026 | Gendel Mitchell SOfficer | Purchase at price 4.43 per share. | 2.5K | $11.07K |
| Aug 3, 2026 | Merton Carl A.Chief Financial Officer | Purchase at price 4.62 per share. | 10K | $46.20K |
| Aug 2, 2026 | Faltischek Denise MOfficer | Purchase at price 4.78 per share. | 2.5K | $11.95K |
| Jul 29, 2026 | Merton Carl A.Chief Financial Officer | — | 77.1K | — |
| Jul 29, 2026 | Faltischek Denise MOfficer | — | 119.8K | — |
| Jul 29, 2026 | Simon Irwin DavidChief Executive Officer | — | 546.1K | — |
| Jul 29, 2026 | Gendel Mitchell SOfficer | — | 111.8K | — |
| Jul 28, 2026 | Hopkinson David G.Director | — | 43.1K | — |
| Jul 28, 2026 | Herhalt Johann MichaelDirector | — | 43.1K | — |
| Jul 28, 2026 | Cohen Steven MichaelDirector | — | 43.1K | — |
| Jul 28, 2026 | Persofsky RenahDirector | — | 43.1K | — |
| Jul 28, 2026 | Clanachan David FDirector | — | 43.1K | — |
| Jul 28, 2026 | Looney Thomas PatrickDirector | — | 43.1K | — |
| Apr 20, 2026 | Hopkinson David G.Director | Sale at price 6.94 per share. | 33.6K | $232.88K |
| Jan 6, 2026 | Cohen Steven MichaelDirector | Conversion of Exercise of derivative security at price 8.99 per share. | 12.4K | $111.82K |
| Jul 30, 2025 | Merton Carl A.Chief Financial Officer | Conversion of Exercise of derivative security at price 0.58 per share. | 93.9K | $54.48K |
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Year |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -17.4 | 5.5 | -17.8 | -3.6 | -11.7 | -18.5 | 1.1 | 0.7 | -17.9 | -14.4 | −64.5% | ||
| 2025 | -21.1 | -29.5 | -10.8 | -25.8 | -12.2 | -4.7 | 41.5 | 137.9 | 25.4 | -22.5 | -39.6 | 11.5 | −32.1% |
| 2024 | -20.4 | -5.5 | 42.8 | 0.0 | -27.1 | -7.8 | 22.3 | -15.8 | 2.9 | -6.8 | -18.3 | -0.7 | −42.2% |
| 2023 | 20.4 | -12.7 | -10.6 | -7.1 | -28.9 | -6.6 | 62.2 | 17.0 | -19.3 | -24.7 | 0.6 | 27.1 | −14.5% |
| 2022 | -15.2 | 2.3 | 27.4 | -35.9 | -9.8 | -30.5 | 17.0 | 4.1 | -27.6 | 48.0 | -4.9 | -30.5 | −61.7% |
| 2021 | 119.1 | 34.6 | -6.7 | -19.3 | -9.1 | 8.5 | -19.2 | -6.3 | -17.5 | -8.8 | -1.7 | -30.5 | −14.9% |
| 2020 | 2.4 | -17.7 | -52.3 | 17.0 | 22.4 | -27.8 | 3.8 | -9.1 | -27.7 | 17.7 | 58.3 | -8.6 | −51.8% |
| 2019 | 14.1 | 1.0 | -19.4 | -21.7 | -25.9 | 22.5 | -12.3 | -37.1 | -3.6 | -9.8 | -11.1 | -13.7 | −75.7% |
| 2018 | 195.0 | 120.3 | -34.0 | 8.1 | -31.1 | +219.2% |
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the company provides entertainment products. It offers its products under the Tilray, Aphria, Broken Coast, Symbios, Navcora, Tilray Craft, Charlotte's Web, Shock Top, Montauk Brewing, 10 Barrell, Breckenridge Brewery, SweetWater Brewing, Breckenridge Distillery, Blue Point, Alpine, Broken Coast, Redecan, XMG, Manitoba Harvest, CC Pharma, Good Supply, Solei, Mollo, Chowie Wowie, Original Stash, Canaca, RIFF, Tilray Medical, Bake Sale, The Batch, HEXO, Cruisies, Atwater Brewery, Hi-ball Energy, Liquid Love, Hop Valley Brewing, Redhook Brewery, Revolver Brewing, Square Mile Cider, Mock One, Widmer Brothers Brewing, Runner's High Brewing Company, SweetWater Brewing Company, Terrapin brands. The company sells its products to retailers, wholesalers, patients, physicians, hospitals, pharmacies, researchers, and governments, as well as direct to consumers. The company was formerly known as Tilray, Inc. and changed its name to Tilray Brands, Inc. in January 2022. Tilray Brands, Inc. is headquartered in Leamington, Canada.
Buy / hold / sell counts
No recent headlines.